NEXGEL, Inc. (NXGL)
NEXGEL, Inc. operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Langhorne, PA, US. The stock last traded at $0.41, down 3.54% on the session, giving a market capitalisation of $3.5M. On trailing twelve-month figures it carries a trailing P/E of -1.04, a net margin of -28.5%. Its beta of 0.77 implies it has historically moved less than the broad market.
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
NEXGEL, Inc. is most often compared with the following Healthcare names: